Vasomotor symptoms market forecast to grow across seven major markets through 2036
AI Summary- DelveInsight published a report on the vasomotor symptoms treatment market and its emerging therapies.
- The market study covers 2022–2036 across seven major markets, with the United States largest in 2025.
- Bayer, AbCellera, Astellas and Noema reported regulatory or clinical developments during 2025 and 2026.